Wojewodzki Szpital Zespolony W Kielcach SPZOZ
- Address
- lock Available on a paid plan
Cardiovascular Diseases Research
At Wojewodzki Szpital Zespolony W Kielcach SPZOZ, clinical trials in cardiovascular diseases focus on major conditions such as myocardial infarction, acute coronary syndrome, acute heart failure, and lower extremity artery disease. These studies are designed to test new treatment approaches, improve recovery after heart events, and evaluate better ways to prevent complications and restenosis.
- Research on therapies for patients with reduced heart function after myocardial infarction
- Studies assessing safer antiplatelet strategies in acute coronary syndrome
- Trials exploring methods to reduce restenosis in lower extremity artery disease
Overall, this area reflects a strong interest in improving treatment effectiveness and long-term outcomes for patients with serious heart and vascular conditions.
Neoplasms and Hematologic Cancer Studies
The site also supports research in neoplasms, with trials involving acute lymphoblastic leukemia and lymphoblastic lymphoma. These studies aim to refine cancer treatment, compare therapy combinations, and improve disease control in children and adolescents affected by blood cancers.
- Studies in acute lymphoblastic leukemia evaluating treatment effectiveness and disease-free survival
- Trials in lymphoblastic lymphoma focused on reducing relapse risk and improving outcomes
- Research comparing standard and intensified treatment strategies in pediatric oncology
This work highlights the role of the hospital clinic in Kielce in advancing more effective and tailored approaches for challenging hematologic malignancies.
Pathological Conditions, Signs and Symptoms Studies
Clinical research in pathological conditions, signs and symptoms includes trials for idiopathic steroid-sensitive nephrotic syndrome. These studies are aimed at improving relapse prevention, comparing treatment options, and assessing the safety and effectiveness of therapies used to maintain remission in patients with recurrent kidney disease.
- Trials evaluating treatment strategies for nephrotic syndrome recurrence
- Research comparing different rituximab regimens for maintaining disease control
- Studies focused on better long-term management of podocytopathies
By examining both effectiveness and safety, these studies aim to support better care for patients living with relapsing kidney disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Medical University Of Lodz1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Wojewodzki Szpital Zespolony W Kielcach SPZOZ
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Assessment of Ticagrelor-Based De-Escalation Antiplatelet Strategies Versus Standard Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients | Agencja Badań Medycznych, Nicolaus Copernicus University | Phase III | Not Recruiting | Feb 2022 | Apr 2026 |
IMP list
lock Showing 1 of 34 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 3 | Unknown | 2017-10-02 | 2022-12-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.